NZX-listed cancer diagnostic company Pacific Edge says it has been told it will have to wait a bit longer for a decision on whether it has a future with or without its make-or-break customer, the US Medicare system.
Novitas, the Medicare Administrative contractor that has responsibility for Pacific
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).